Coherus BioSciences’ $57.5 Million Follow-On Offering

Leila Ahmed
Tagged:

Latham & Watkins advised Coherus BioSciences, and Davis Polk advised J.P. Morgan Securities LLC and Citigroup Global Markets Inc. on the offering.Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), a…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Leila Ahmed

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here